Compare ALG & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | TARS |
|---|---|---|
| Founded | 1955 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 1993 | 2020 |
| Metric | ALG | TARS |
|---|---|---|
| Price | $173.61 | $82.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $225.00 | $76.56 |
| AVG Volume (30 Days) | 128.5K | ★ 539.1K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.64 | N/A |
| Revenue | ★ $1,615,388,000.00 | $366,100,000.00 |
| Revenue This Year | $1.26 | $147.24 |
| Revenue Next Year | $5.09 | $53.11 |
| P/E Ratio | $18.01 | ★ N/A |
| Revenue Growth | N/A | ★ 182.44 |
| 52 Week Low | $156.30 | $38.51 |
| 52 Week High | $233.29 | $85.25 |
| Indicator | ALG | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 61.87 |
| Support Level | $170.04 | $77.14 |
| Resistance Level | $176.42 | $83.34 |
| Average True Range (ATR) | 4.44 | 2.85 |
| MACD | 0.86 | -0.24 |
| Stochastic Oscillator | 59.23 | 66.24 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.